Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study.

Authors

Ali Yilmaz, Beaumont Health
Zafer Ugur, Beaumont Health
Halil Bisgin, Beaumont Health
Sumeyya Akyol, Beaumont Health
Ray Bahado-Singh, Beaumont Health
George Wilson, Beaumont Health
Khaled Imam, Beaumont Health
Michael E Maddens, Beaumont Health
Stewart F Graham, Beaumont Health

Document Type

Article

Publication Date

8-31-2020

Publication Title

Metabolites

Abstract

The lack of sensitive and specific biomarkers for the early detection of mild cognitive impairment (MCI) and Alzheimer's disease (AD) is a major hurdle to improving patient management. A targeted, quantitative metabolomics approach using both

Volume

10

Issue

9

Recommended Citation

Yilmaz A, Ugur Z, Bisgin H, Akyol S, Bahado-Singh R, Wilson G, Imam K, Maddens ME, Graham SF. Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study. Metabolites. 2020 Aug 31;10(9):357. doi: 10.3390/metabo10090357. PMID: 32878308; PMCID: PMC7569858.

DOI

10.3390/metabo10090357

ISSN

2218-1989

PubMed ID

32878308